Jean Luc Gardette
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jean Luc Gardette.
Experimental Biology and Medicine | 1984
Véronique Barbu; Charles Roux; Rolande Dupuis; Jean Luc Gardette; Jean-Claude Mazière
Abstract An inhibitor of cholesterol synthesis, AY 9944 (trans-1,4-bis(2-chlorobenzylaminomethyl) cyclohexane dihydrochloride) is teratogenic. A single dose of AY 9944 (50 mg/kg or 75 mg/kg) given to Wistar pregnant rats on the second, fourth, sixth, seventh, or eighth day of gestation induced malformations such as holoprosencephaly. They were often limited to isolated pituitary agenesis. The highest percentage of holoprosencephalic fetuses was found when AY 9944 was given on the fourth day of gestation. Whatever the dose and the day of administration, the lower the maternal plasma cholesterol level, the more frequent were holoprosencephalic fetuses. Therefore, it is suggested that the decrease in maternal plasma cholesterol level is at least one of the factors provoking holoprosencephaly.
Biochemical and Biophysical Research Communications | 1983
J.C. Mazière; C. Mazière; Jean Luc Gardette; Liliana Mora; Jacques Polonovski
Pretreatment of cultured human fibroblasts by cyclic AMP resulted in a marked decrease in the binding and internalization of the low density lipoproteins (about 55% of controls for cyclic AMP 2.10(-3) M). This effect was dose dependent and increased by theophyllin. DL propranolol, an inhibitor of adenylcyclase, had an opposite effect. Isoproterenol, which stimulates adenylcyclase, reproduced the effect of cyclic AMP. The cholesterol synthesis from [2-14C] acetate was decreased by cyclic AMP, theophyllin and isoproterenol, and increased by propranolol. The incorporation of [1-14C] oleate into cholesteryl esters was reduced by cyclic AMP, theophyllin, isoproterenol and propranolol.
Biochemical and Biophysical Research Communications | 1985
C. Mazière; J.C. Mazière; Liliana Mora; Jean Luc Gardette; Jacques Polonovski
The effect of epinephrine on 125I-low density lipoprotein (LDL) uptake and cholesterol metabolism was investigated after a 24 hours pretreatment of cultured human fibroblasts. Epinephrine decreased LDL uptake (binding + internalization) and degradation in a dose-dependent manner. Cholesterol synthesis from 14C sodium acetate and cholesterol esterification measured by 14C oleic acid incorporation into cholesteryl esters were also decreased. These results are in agreement with the general view that epinephrine increases cyclic AMP intracellular level, as it was previously demonstrated that dibutyryl cyclic AMP or isoproterenol treatment of cultured fibroblasts had similar effect on these pathways. The decrease in LDL processing induced by epinephrine could be involved in the worsening effect of epinephrine on atherosclerosis.
Polymer Degradation and Stability | 1983
Norman S. Allen; Alan Parkinson; Jean Luc Gardette; Jacques Lemaire
Abstract The thermal oxidation behaviour of three hindered piperidine compounds has been examined in polypropylene film by oven ageing in air at 140°C together with its subsequent effect on rate of photo-oxidation. The amine, bis[2,2,6,6-tetramethyl-4-piperidinyl] sebacate, shows a rapid growth in nitroxyl radical concentration due to reaction with hydroperoxides whereas the bis-nitroxyl derivative is relatively stable and decreases in concentration very slowly, giving the hydroxylamine. The ageing process results in an improvement in photo-stability and this is associated with the reaction of the nitroxyl radical with a tertiary radical to give the hydroxylamine and ethylenic unsaturation. The mono nitroxyl compound behaves differently during the early stages of ageing in that there is a rapid decrease in concentration and this is followed by a rapid fall in photo-stability. Only during the latter stages of ageing does hydroxylamine production appear to control photo-stability.
Atherosclerosis | 1988
J.C. Mazière; C. Mazière; Liliana Mora; Jean Luc Gardette; Suzanne Salmon; Martine Auclair; Jacques Polonovski
The effect of the hypoglycemic biguanide drug Metformin was investigated after a 72 h pretreatment of human cultured fibroblasts. Metformin induced a moderate increase in low density lipoprotein binding, uptake and internalization (25% increase after treatment with 5 X 10(-4) M of drug). A decrease in sterol, fatty acid and triacyglycerol synthesis from sodium acetate was observed after pretreatment with the drug, with a dose-dependent effect in the range of 5 X 10(-5) to 5 X 10(-4) M (50% reduction of sterol synthesis after treatment with Metformin 5 X 10(-4) M). This effect was also observed in fibroblasts from a patient with homozygous familial hypercholesterolemia. Cholesterol esterification studied by incorporation of radiolabeled oleic acid was reduced by Metformin (40% of control after treatment with Metformin 5 X 10(-4) M) whereas incorporation into triacylglycerols was less impaired. These effects of Metformin on cholesterol metabolism were observed either in the presence or in the absence of low density lipoproteins. Moreover, Metformin also reduced cholesterol esterification in J774 monocyte-macrophage cells. Metformin also induced a decrease of hydroxymethylglutaryl coenzyme A reductase activity in cultured fibroblasts and a reduction of acyl-coenzyme A: cholesterol-O-acyltransferase activity in cultured fibroblasts and J774 cells.
FEBS Letters | 1983
J.C. Mazière; C. Mazière; Jean Luc Gardette; J.D. Routier; Claude Wolf; D. Rainteau; Jacques Polonovski
Treatment of cultured human fibroblasts with trifluoperazine or chlorpromazine resulted in a biphasic effect on low density lipoprotein (LDL) catabolism, depending upon the dose. At up to 10−5 M, a marked increase in LDL binding, internalization and degradation was observed. This phenomenon took place within the first hours of incubation with the drugs, suggesting a direct effect on cell membrane physical characteristics, probably related to the lipophilic properties of phenothiazines. Concentrations above 2 × 10−5 M resulted in a relative decrease in LDL binding and internalization, and in a dramatic decrease in LDL degradation, which may be related to an inhibition of calmodulin‐dependent processes.
FEBS Letters | 1984
J.C. Mazière; C. Mazière; Liliana Mora; Jean Luc Gardette; Jacques Polonovski
Pretreatment of cultured human fibroblasts with the calcium ionophore A 23187 resulted in a decrease in low‐density lipoprotein internalization. This effect was dose‐dependent and did not occur in a medium devoid of calcium. About 2‐fold reduction was observed with 10−5 M A 23187. In contrast, the low‐density lipoprotein binding was only slightly affected. The incorporation of [14C]acetate and [14C]oleate into all classes of lipids (sterol, triacylglycerols and phospholipids) was strikingly reduced by ionophore pretreatment.
Biochemical and Biophysical Research Communications | 1984
J.C. Mazière; C. Mazière; Liliana Mora; Jean Luc Gardette; Claude Wolf; D. Rainteau; Véronique Barbu; C. Roux; Jacques Polonovski
Treatment of cultured human fibroblasts with the hypocholesterolemic drug AY 9944 resulted in a marked increase in low density lipoprotein internalization and degradation for concentrations up to 5 X 10(-6)M. Low density lipoprotein binding was less affected. Concentrations above 5 X 10(-6)M resulted in a relative decrease in low density lipoprotein degradation, whereas binding and internalization plateaued. The stimulation of low density lipoprotein internalization took place within the first hours of incubation of cells with the drug, which suggests a direct effect on the cell membrane. Such phenomenon could account at least partially for the hypocholesterolemic effect of the drug, besides its inhibitory effect on 7-dehydrocholesterol reductase.
Biochemical and Biophysical Research Communications | 1987
N.E. Houtia; J.C. Mazière; C. Mazière; Martine Auclair; Liliana Mora; Jean Luc Gardette; Jacques Polonovski
The effect of dibutyryl-cyclic AMP (dbcAMP) and theophylline was investigated on oleic acid incorporation into cholesteryl esters and triacylglycerols in the mouse monocyte-macrophage cell line J 774. 24h pretreatment of macrophages with dbcAMP decreased cholesteryl ester formation in a dose-dependent manner (about 4 fold reduction for dbcAMP 10(-4)M + theophylline 10(-3)M), while oleic acid incorporation into triacylglycerols was markedly (2 to 3 fold) enhanced. The catabolism of acetylated LDL was only slightly affected (about 15-20% reduction with dbcAMP 5 X 10(-4)M + theophylline 10(-3)M). Acyl Coenzyme A: cholesterol-O-acyl-transferase activity, measured in vitro on cell homogenates, was reduced in dbcAMP-treated cells, whereas diacylglycerol acyltransferase activity was increased. These results suggest that cyclic AMP can modulate cholesteryl ester and triacylglycerol formation in macrophages, and that these metabolisms are inversely regulated. Agents which increase cyclic AMP intracellular level could be of interest for reducing cholesteryl ester accumulation in macrophages.
Biochemical and Biophysical Research Communications | 1981
J.C. Mazière; C. Mazière; Jean Luc Gardette; Liliana Mora; Jacques Polonovski
Abstract Cultured skin fibroblasts from 6 patients with Niemann-Pick disease type A were investigated for cholesterol metabolism. An increase in cholesterol synthesis from 14C-sodium acetate was observed in all cases. A decrease in 14C-oleic acid incorporation into cholesteryl esters was found in 5 of 6 cases. 125I-low density lipoprotein binding was significantly reduced in 3 of 4 investigated cases.